An asset purchase agreement has been signed with Dexcel Pharma USA, which will acquire the full rights to Zubsolv® in the US, at a purchase price of USD 91 million plus the value of inventory at closi ...
Life is hectic, and juggling dozens of apps for the "must-do" chores adds to the noise. Since I already work in Excel daily, I've expanded its use to automate three of my most boring tasks. These ...
The following discussion contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are statements that could be ...